MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1126/sciadv.ady5599

Медицинская библиотека · Science advances · 2025

Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastoma.

Han Jeremy Z R, Phimmachanh Monica, Hastings Jordan F, Leong King Ho, Ng Boaz H, Ni Jenny, Fontaine-Titley Angela, Cadell Antonia L, O'Donnell Yolande Ei, Clearwater Misaki, Kamili Alvin, Haber Michelle, Norris Murray, Timpson Paul, Trahair Toby N, Fletcher Jamie I, Fey Dirk, Kolch Walter, Latham Sharissa L, Croucher David R

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

The acquisition of a chemoresistant state underlies poor prognosis in many cancers, including neuroblastoma. We previously demonstrated that heterogeneity in apoptosis induction through c-Jun amino-terminal kinase (JNK) promotes a form of nongenetic chemoresistance in neuroblastoma observable at both patient and single-cell levels. As the maintenance of this JNK-impaired state in the relapse setting is a substantial barrier to the efficacy of many standard-of-care chemotherapy drugs, we combined a mechanistic, mathematical model of JNK activation with a pediatric-focused drug screen and identified approved oncology drugs capable of inducing apoptosis in a JNK-independent manner. Functional genomics further revealed that synergy between these JNK-independent drugs and standard-of-care chemotherapies emerged from differential utilization of apoptotic network components, rather than from their direct mechanistic targets. Efficacy studies with patient-derived xenograft models also confirmed that including a JNK-independent drug within existing chemotherapy backbones significantly improved response in the relapse setting, where new approaches are urgently needed.

Для цитирования: Han Jeremy Z R, Phimmachanh Monica, Hastings Jordan F, Leong King Ho, Ng Boaz H, Ni Jenny, Fontaine-Titley Angela, Cadell Antonia L, O'Donnell Yolande Ei, Clearwater Misaki, Kamili Alvin, Haber Michelle, Norris Murray, Timpson Paul, Trahair Toby N, Fletcher Jamie I, Fey Dirk, Kolch Walter, Latham Sharissa L, Croucher David R. Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastoma.. Science advances. 2025. DOI: 10.1126/sciadv.ady5599.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.